newsfilter
← Latest News
GlobeNewswire·

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

– Announced strategic research collaboration with Chugai for two undisclosed molecules – – Presented preclinical data demonstrating bioequivalence of novel, bispecific GLP-1/GLP-2 receptor agonist delivered orally